# Ranpak Holdings Corp.: financial statements, quarterly

PACK · NYSE · CIK 1712463 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pack.md) · [Financials](/companies/pack/financials.md) · [Filings](/companies/pack/filings.md) · [Insiders](/companies/pack/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pack/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [69.6](/filings/0001628280-24-044469.md) | [77.6 d](/filings/0001628280-26-015027.md) | [72.5](/filings/0001628280-25-022452.md) | [72.8](/filings/0001628280-25-037617.md) | [78.6](/filings/0001628280-25-047394.md) | [91.6 d](/filings/0001628280-26-015027.md) | [77.6](/filings/0001628280-26-028666.md) | [77.8](/filings/0001628280-26-050839.md) | [83.6](/filings/0001628280-25-047394.md) | [93.7 d](/filings/0001628280-26-015027.md) | [81.8](/filings/0001628280-26-028666.md) | [86.4](/filings/0001628280-26-050839.md) |
| Cost of revenue | $m | [51.3](/filings/0001628280-24-044469.md) | [56.3 d](/filings/0000950170-24-031390.md) | [53.0](/filings/0000950170-24-051610.md) | [54.7](/filings/0001628280-24-033913.md) | [57.8](/filings/0001628280-24-044469.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [31.5](/filings/0001628280-24-044469.md) | [34.1 d](/filings/0001628280-26-015027.md) | [32.3](/filings/0001628280-25-022452.md) | [31.7](/filings/0001628280-25-037617.md) | [34.4](/filings/0001628280-25-047394.md) | [41.4 d](/filings/0001628280-26-015027.md) | [30.9](/filings/0001628280-26-028666.md) | [28.9](/filings/0001628280-26-050839.md) | [34.4](/filings/0001628280-25-047394.md) | [36.5 d](/filings/0001628280-26-015027.md) | [34.9](/filings/0001628280-26-028666.md) | [34.5](/filings/0001628280-26-050839.md) |
| Selling, general and administrative | $m | [20.9](/filings/0001628280-24-044469.md) | [27.4 d](/filings/0001628280-26-015027.md) | [27.9](/filings/0001628280-25-022452.md) | [27.3](/filings/0001628280-25-037617.md) | [28.8](/filings/0001628280-25-047394.md) | [27.9 d](/filings/0001628280-26-015027.md) | [28.9](/filings/0001628280-26-028666.md) | [28.8](/filings/0001628280-26-050839.md) | [29.6](/filings/0001628280-25-047394.md) | [27.2 d](/filings/0001628280-26-015027.md) | [29.2](/filings/0001628280-26-028666.md) | [27.6](/filings/0001628280-26-050839.md) |
| Operating income | $m | [1.6](/filings/0001628280-24-044469.md) | [(4.6) d](/filings/0001628280-26-015027.md) | [(4.8)](/filings/0001628280-25-022452.md) | [(5.2)](/filings/0001628280-25-037617.md) | [(4.2)](/filings/0001628280-25-047394.md) | [1.4 d](/filings/0001628280-26-015027.md) | [(8.0)](/filings/0001628280-26-028666.md) | [(9.7)](/filings/0001628280-26-050839.md) | [(5.7)](/filings/0001628280-25-047394.md) | [(0.9) d](/filings/0001628280-26-015027.md) | [(3.8)](/filings/0001628280-26-028666.md) | [(2.4)](/filings/0001628280-26-050839.md) |
| Interest expense | $m | [6.8](/filings/0000950170-23-057578.md) | [5.9 d](/filings/0000950170-24-031390.md) | [6.2](/filings/0000950170-24-051610.md) | [5.3](/filings/0001628280-25-037617.md) | [9.3](/filings/0001628280-25-047394.md) | [7.8 d](/filings/0001628280-26-015027.md) | [8.7](/filings/0001628280-26-028666.md) | [8.3](/filings/0001628280-26-050839.md) | [8.7](/filings/0001628280-25-047394.md) | [8.6 d](/filings/0001628280-26-015027.md) | [8.6](/filings/0001628280-26-028666.md) | [8.1](/filings/0001628280-26-050839.md) |
| Income tax | $m | [(1.1)](/filings/0001628280-24-044469.md) | [(1.3) d](/filings/0001628280-26-015027.md) | [(1.5)](/filings/0001628280-25-022452.md) | [1.8](/filings/0001628280-25-037617.md) | [(2.5)](/filings/0001628280-25-047394.md) | [0.0 d](/filings/0001628280-26-015027.md) | [(3.2)](/filings/0001628280-26-028666.md) | [(2.0)](/filings/0001628280-26-050839.md) | [(4.2)](/filings/0001628280-25-047394.md) | [0.2 d](/filings/0001628280-26-015027.md) | [(3.5)](/filings/0001628280-26-028666.md) | [(2.9)](/filings/0001628280-26-050839.md) |
| Net income | $m | [(3.3)](/filings/0001628280-24-044469.md) | [(9.3) d](/filings/0001628280-26-015027.md) | [(8.1)](/filings/0001628280-25-047394.md) | [5.5](/filings/0001628280-25-047394.md) | [(8.1)](/filings/0001628280-25-047394.md) | [(10.8) d](/filings/0001628280-26-015027.md) | [(10.9)](/filings/0001628280-26-050839.md) | [(7.5)](/filings/0001628280-26-050839.md) | [(10.4)](/filings/0001628280-25-047394.md) | [(9.5) d](/filings/0001628280-26-015027.md) | [(10.2)](/filings/0001628280-26-050839.md) | [(7.9)](/filings/0001628280-26-050839.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001628280-24-044469.md) | not reported | [(0.10)](/filings/0001628280-25-022452.md) | [0.07](/filings/0001628280-25-037617.md) | [(0.10)](/filings/0001628280-25-047394.md) | not reported | [(0.13)](/filings/0001628280-26-028666.md) | [(0.09)](/filings/0001628280-26-050839.md) | [(0.12)](/filings/0001628280-25-047394.md) | not reported | [(0.12)](/filings/0001628280-26-028666.md) | [(0.09)](/filings/0001628280-26-050839.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001628280-24-044469.md) | not reported | [(0.10)](/filings/0001628280-25-022452.md) | [0.07](/filings/0001628280-25-037617.md) | [(0.10)](/filings/0001628280-25-047394.md) | not reported | [(0.13)](/filings/0001628280-26-028666.md) | [(0.09)](/filings/0001628280-26-050839.md) | [(0.12)](/filings/0001628280-25-047394.md) | not reported | [(0.12)](/filings/0001628280-26-028666.md) | [(0.09)](/filings/0001628280-26-050839.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.1](/filings/0000950170-23-057578.md) | [62.0](/filings/0001628280-25-012927.md) | [55.1](/filings/0000950170-24-051610.md) | [65.1](/filings/0001628280-24-033913.md) | [69.5](/filings/0001628280-24-044469.md) | [76.1](/filings/0001628280-26-015027.md) | [65.5](/filings/0001628280-25-022452.md) | [49.2](/filings/0001628280-25-037617.md) | [49.9](/filings/0001628280-25-047394.md) | [63.0](/filings/0001628280-26-050839.md) | [48.5](/filings/0001628280-26-028666.md) | [43.2](/filings/0001628280-26-050839.md) |
| Current assets | $m | [123](/filings/0000950170-23-057578.md) | [125](/filings/0001628280-25-012927.md) | [125](/filings/0000950170-24-051610.md) | [148](/filings/0001628280-24-033913.md) | [153](/filings/0001628280-24-044469.md) | [151](/filings/0001628280-26-015027.md) | [157](/filings/0001628280-25-022452.md) | [152](/filings/0001628280-25-037617.md) | [147](/filings/0001628280-25-047394.md) | [154](/filings/0001628280-26-050839.md) | [144](/filings/0001628280-26-028666.md) | [146](/filings/0001628280-26-050839.md) |
| Total assets | $m | [1,119](/filings/0000950170-23-057578.md) | [1,123](/filings/0001628280-25-012927.md) | [1,107](/filings/0000950170-24-051610.md) | [1,120](/filings/0001628280-24-033913.md) | [1,133](/filings/0001628280-24-044469.md) | [1,104](/filings/0001628280-26-015027.md) | [1,120](/filings/0001628280-25-022452.md) | [1,138](/filings/0001628280-25-037617.md) | [1,130](/filings/0001628280-25-047394.md) | [1,125](/filings/0001628280-26-050839.md) | [1,107](/filings/0001628280-26-028666.md) | [1,097](/filings/0001628280-26-050839.md) |
| Current liabilities | $m | [45.9](/filings/0000950170-23-057578.md) | [48.0](/filings/0001628280-25-012927.md) | [51.3](/filings/0000950170-24-051610.md) | [58.6](/filings/0001628280-24-033913.md) | [64.8](/filings/0001628280-24-044469.md) | [68.4](/filings/0001628280-26-015027.md) | [87.7](/filings/0001628280-25-022452.md) | [87.3](/filings/0001628280-25-037617.md) | [78.2](/filings/0001628280-25-047394.md) | [84.0](/filings/0001628280-26-050839.md) | [83.2](/filings/0001628280-26-028666.md) | [81.3](/filings/0001628280-26-050839.md) |
| Total liabilities | $m | [542](/filings/0000950170-23-057578.md) | [551](/filings/0001628280-25-012927.md) | [547](/filings/0000950170-24-051610.md) | [554](/filings/0001628280-24-033913.md) | [569](/filings/0001628280-24-044469.md) | [556](/filings/0001628280-26-015027.md) | [575](/filings/0001628280-25-022452.md) | [599](/filings/0001628280-25-037617.md) | [592](/filings/0001628280-25-047394.md) | [590](/filings/0001628280-26-050839.md) | [583](/filings/0001628280-26-028666.md) | [577](/filings/0001628280-26-050839.md) |
| Long-term debt | $m | [390](/filings/0000950170-23-057578.md) | [398](/filings/0001628280-25-012927.md) | [394](/filings/0000950170-24-051610.md) | [394](/filings/0001628280-24-033913.md) | [401](/filings/0001628280-24-044469.md) | [401](/filings/0001628280-26-015027.md) | [400](/filings/0001628280-25-022452.md) | [398](/filings/0001628280-25-037617.md) | [397](/filings/0001628280-25-047394.md) | [396](/filings/0001628280-26-050839.md) | [397](/filings/0001628280-26-028666.md) | [396](/filings/0001628280-26-050839.md) |
| Current portion of debt | $m | [1.5](/filings/0000950170-23-057578.md) | [1.6](/filings/0001628280-25-012927.md) | [1.6](/filings/0000950170-24-051610.md) | [1.6](/filings/0001628280-24-033913.md) | [1.1](/filings/0001628280-24-044469.md) | [4.0](/filings/0001628280-26-015027.md) | [4.0](/filings/0001628280-25-022452.md) | [3.9](/filings/0001628280-25-037617.md) | [4.3](/filings/0001628280-25-047394.md) | [3.9](/filings/0001628280-26-050839.md) | [5.1](/filings/0001628280-26-028666.md) | [5.3](/filings/0001628280-26-050839.md) |
| Shareholders' equity | $m | [578](/filings/0001628280-24-044469.md) | [572](/filings/0001628280-26-015027.md) | [560](/filings/0001628280-25-047394.md) | [566](/filings/0001628280-25-047394.md) | [564](/filings/0001628280-25-047394.md) | [548](/filings/0001628280-26-050839.md) | [544](/filings/0001628280-26-050839.md) | [539](/filings/0001628280-26-050839.md) | [538](/filings/0001628280-25-047394.md) | [535](/filings/0001628280-26-050839.md) | [525](/filings/0001628280-26-050839.md) | [520](/filings/0001628280-26-050839.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.4 d](/filings/0001628280-24-044469.md) | [29.6 d](/filings/0001628280-26-015027.md) | [5.2](/filings/0001628280-25-022452.md) | [19.6 d](/filings/0001628280-25-037617.md) | [10.1 d](/filings/0001628280-25-047394.md) | [6.5 d](/filings/0001628280-26-015027.md) | [(1.3)](/filings/0001628280-26-028666.md) | [(3.6) d](/filings/0001628280-26-050839.md) | [8.5 d](/filings/0001628280-25-047394.md) | [19.5 d](/filings/0001628280-26-015027.md) | [4.4](/filings/0001628280-26-028666.md) | [2.7 d](/filings/0001628280-26-050839.md) |
| Capital expenditure | $m | [9.7 d](/filings/0000950170-23-057578.md) | [20.4 d](/filings/0000950170-24-031390.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [82.0](/filings/0000950170-23-057578.md) | [82.1](/filings/0000950170-24-051610.md) | [82.4](/filings/0001628280-24-033913.md) | [82.3](/filings/0001628280-24-044469.md) | [82.7](/filings/0001628280-25-022452.md) | [83.1](/filings/0001628280-25-037617.md) | [83.2](/filings/0001628280-25-047394.md) | [83.7](/filings/0001628280-26-028666.md) | [84.3](/filings/0001628280-26-050839.md) | [84.4](/filings/0001628280-25-047394.md) | [84.8](/filings/0001628280-26-028666.md) | [85.6](/filings/0001628280-26-050839.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 85,758,289 at 2026-07-23, from the cover of the [10-Q filed 2026-07-30](/filings/0001628280-26-050839.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.